Oviva, a digital provider of Type 2 diabetes treatment in Europe, has raised US$21m in Series B funding to expand across Europe. “The new financing allows us to roll out our…
Oviva, a digital provider of Type 2 diabetes treatment in Europe, has raised US$21m in Series B funding to expand across Europe. “The new financing allows us to roll out our…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference